Tag: Intas Pharmaceuticals Ltd

Intas Pharmaceuticals Launches HETRONIFLY™ (Serplulimab), India’s First Novel Immunotherapy for Advanced Small Cell Lung Cancer

AHMEDABAD, India, Aug. 5, 2025 /PRNewswire/ -- Intas Pharmaceuticals has launched HETRONIFLY™ (Serplulimab), the first PD-1 inhibitor globally approved for the treatment of Extensive-Stage...

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Comments

This field is for validation purposes and should be left unchanged.

HomeTagsIntas Pharmaceuticals Ltd

Thyseed Newborn Baby Bottle with Bottom Vent Design: Clinically Proven to Reduce Colic and Spit-up by 30%

ADNOC Gas Announces Record Second Quarter Performance, Demonstrating Resilience in Lower Price Environment

Baltic Horizon Fund publishes interest rate applicable to the bonds for the next interest period

Tag: Intas Pharmaceuticals Ltd

Intas Pharmaceuticals Launches HETRONIFLY™ (Serplulimab), India’s First Novel Immunotherapy for Advanced Small Cell Lung Cancer

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us